Clinical Trial

Phase I Study of Carbon-Ion Lattice Radiotherapy for Large Thoracic Tumors

Study acronym: CILAT-I
Recruiting
View on ClinicalTrials.gov →
Summary
This is the first prospective clinical study to evaluate the efficacy and safety of induction chemoimmunotherapy followed by carbon ion radiotherapy and consolidation immunotherapy in patients with unresectable locally advanced non-small cell lung cancer (NSCLC). Based on this prospective study, tumor tissue, blood, urine, and stool samples from participants will be collected and analyzed to identify predictive markers of treatment response.
Trial Details
NCT Number NCT07744074
Lead Sponsor Ji Yongling
Conditions Carbon Ion Radiotheray
Enrollment 12 participants
Start Date 2026-05-26
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-04